Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/71043

TítuloDevelopment of an electrochemical biosensor for Galectin-3 detection in point-of-care
Autor(es)Cerqueira, Sofia M. V.
Fernandes, Rúben
Moreira, Felismina
Sales, M. G. F.
Palavras-chaveMelanoma
Screen-printed-electrode
Molecularly-imprinted polymer
Biosensor
Galectin-3
Data2021
EditoraElsevier 1
RevistaMicrochemical Journal
CitaçãoCerqueira, Sofia M. V.; Fernandes, Rúben; Moreira, Felismina; Sales, M. G. F., Development of an electrochemical biosensor for Galectin-3 detection in point-of-care. Microchemical Journal, 164(105992), 2021
Resumo(s)This research work aims the development and optimization of an electrochemical biosensor based on molecularly-imprinted polymers [MIPs], for monitoring a melanoma biomarker, Galectin-3 (Gal-3). As it is a multifunctional protein that plays an important role in different types of tumors including melanoma, and has shown good results as a potential biomarker in several areas, the construction of a biosensor for the detection of this protein would be a simple and quick strategy to support the treatment of this type of pathology. The target molecule was recognized by a MIP material, created on the electrodes surface by electropolymerizing a mixture of analyte (Gal-3) and monomer (2-aminophenol). Then, the protein was removed from the polymeric material by oxalic acid treatment. This process formed a non-conductive polymer with recognition sites showing affinity for the Gal-3. The control of the surface modification was monitored by Raman spectroscopy and electroanalytical techniques, namely electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). The analytical performance of the sensor was evaluated by EIS, by following the analytical response of standard solutions ranging from 0.5 ng/mL to 5000 ng/mL Gal-3 in spyked serum. In general, the biosensor displayed good analytical features, considering limit of detection, response time and reproducibility. Overall, this study resulted from the need to create a new strategy for monitoring melanoma through the creation of a cheaper, faster and sensitive device, which can be commercialized and thus integrate the entire process associated with the treatment and follow-up of this pathology.
TipoArtigo
URIhttps://hdl.handle.net/1822/71043
DOI10.1016/j.microc.2021.105992
ISSN0026-265X
e-ISSN1095-9149
Versão da editorahttps://www.journals.elsevier.com/microchemical-journal
Arbitragem científicayes
AcessoAcesso restrito UMinho
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_54245_1.pdf
Acesso restrito!
942,29 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID